Moroctocog alfa biosimilar (International Biotech Center Generium)

莫罗凝血素生物类似药 (International Biotech Center Generium)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMoroctocog alfa biosimilar (International Biotech Center Generium)

Drug Alias Name莫罗凝血素α生物仿制药 (International Biotech Center Generium)Moroctocog alfa (International Biotech Center Generium)莫罗凝血素生物仿制药 (International Biotech Center Generium)Human blood coagulation factor VIII (International Biotech Center Generium)Moroctocogum alfa (International Biotech Center Generium) +[9]

ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant coagulation factorBiologics > Biosimilar

Mechanisms of ActionCoagulation factor VIII replacementsCoagulation factor X stimulantsBlood coagulation pathway activation

TargetsCoagulation factor X

Therapy Area/IndicationsHemophilia A

Global Approved IndicationsHemophilia A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryRussian Federation

Original Approved Date2013/01/01

Country/TerritoryRussian Federation

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesInternational Biotech Center Generium

China Registration ClassN/A

Develop Information

Active CompaniesInternational Biotech Center Generium

Inactive CompaniesN/A

Active IndicationsHemophilia A

Inactive IndicationsN/A

Other Information

ATC CodeB02BD02